Patient Training About the Safety of Warfarin Therapy
NCT02757482 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63
Last updated 2016-05-02
Summary
The purpose of this study is to examine the effects of patient training about the safety of warfarin therapy on related knowledge levels and on International Normalized Ratio (INR) control.
Conditions
- Warfarin Knowledge Level
- International Normalized Ratio Control
- Patient Training
Interventions
- OTHER
-
training
Sponsors & Collaborators
-
Celal Bayar University
lead OTHER
Principal Investigators
-
TULAY SAGKAL MIDILLI, Phd, RN · Assistant professor
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-06-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Inr Tracking Coumadin Use With Phone App
NCT05715541 ·Status: COMPLETED ·Phase: NA
-
Early Identification of Warfarin Maintenance Dosage
NCT01178034 ·Status: COMPLETED ·Phase: PHASE3
-
The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
NCT00247702 ·Status: UNKNOWN ·Phase: NA
-
Genotype-guided Warfarin Individualized Treatment
NCT02211326 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
NCT06269302 ·Status: COMPLETED
-
Education Program for Patients Receiving Oral Anticoagulation
NCT01339611 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of a Didactic Intervention in Anticoagulated Patients (TAOPE Study)
NCT03647254 ·Status: UNKNOWN ·Phase: NA
-
Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin
NCT03125668 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients
NCT02592980 ·Status: UNKNOWN ·Phase: PHASE4
-
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
NCT02017197 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Education Level on Clinical Outcomes in Self-INR Managed Patients
NCT06187155 ·Status: RECRUITING ·Phase: NA
-
Clarification of Optimal Anticoagulation Through Genetics
NCT00839657 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Effectiveness and Safety Between Warfarin and Dabigatran
NCT03254134 ·Status: COMPLETED
-
Genetic Response to Warfarin in Healthy Subjects
NCT01520402 ·Status: COMPLETED ·Phase: NA
-
Genotype-Guided Warfarin Therapy Trial
NCT00904293 ·Status: COMPLETED ·Phase: NA
-
Daily Vitamin K in Patients on Warfarin With Unstable INRs
NCT00287313 ·Status: COMPLETED ·Phase: NA
-
Warfarin - How Good Are we at Maintaining Target Range ?
NCT01081327 ·Status: COMPLETED
-
Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer
NCT03180567 ·Status: UNKNOWN ·Phase: NA
-
Assessing the Ability of Warfarin Treated Patients to Predict Their INR
NCT02764112 ·Status: COMPLETED
-
The Study of Warfarin Maintenance Dose in Chinese Patients
NCT01855737 ·Status: UNKNOWN
-
Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy
NCT01392040 ·Status: COMPLETED
-
Patient Self Testing of Warfarin Therapy
NCT00594828 ·Status: UNKNOWN ·Phase: PHASE4
-
Gene-guided Warfarin for Anticoagulation Therapy
NCT04482842 ·Status: WITHDRAWN ·Phase: NA
-
Self-management of Anticoagulation Treatment
NCT02864537 ·Status: COMPLETED ·Phase: NA
-
Prevention of Cefoperazone-induced Coagulopathy
NCT05742295 ·Status: COMPLETED ·Phase: PHASE4